{
    "2018-03-06": [
        [
            {
                "time": "2018-01-01",
                "original_text": "Companies Making Huge Stock Buybacks in 2018",
                "features": {
                    "keywords": [
                        "stock buybacks",
                        "huge"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Profit From Share Buyback Boom With These ETFs",
                "features": {
                    "keywords": [
                        "profit",
                        "share buyback",
                        "ETFs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "Gilead Sciences’ Valuation in March 2018",
                "features": {
                    "keywords": [
                        "Gilead",
                        "valuation"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Bristol-Myers Squibb’s Eliquis and Orencia Saw Solid Growth in 2017",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "Eliquis",
                        "Orencia",
                        "solid growth"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Gilead Announces Positive Data on New HIV Therapy Biktarvy",
                "features": {
                    "keywords": [
                        "Gilead",
                        "positive data",
                        "HIV therapy",
                        "Biktarvy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}